Maravai LifeSciences Holdings,

Historical 13F Holders

Symbol
MRVI
CUSIP
56600D107
All holders as of
Q3 2026
Type
Equity
Class
COM CL A
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 56600D107 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A 5.9% 10/17/2025
Event 9/30/2025
Millennium Management LLC 13G
5.2% 9/29/2026
Event 9/22/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Vanguard Group Inc 13G/A 4.9% 10/31/2025
Event 9/30/2025
12 West Capital Management LP 13G/A
4.9% 5/15/2026
Event 3/31/2026
Stuart Feldman 13G/A
2.5% 8/13/2026
Event 6/30/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 204 145 M $1.11B
2026 Q2 179 140 M $876M
2026 Q1 159 121 M $344M
2025 Q4 162 130 M $424M
2025 Q3 161 131 M $375M
2025 Q2 151 130 M $313M
2025 Q1 187 129 M $284M
2024 Q4 189 141 M $769M
2024 Q3 220 144 M $1.20B
2024 Q2 209 148 M $1.06B
2024 Q1 212 136 M $1.18B
2023 Q4 224 135 M $884M
2023 Q3 208 135 M $1.35B
2023 Q2 223 127 M $1.58B
2023 Q1 222 128 M $1.79B
2022 Q4 214 127 M $1.81B
2022 Q3 204 131 M $3.33B
2022 Q2 217 131 M $3.73B
2022 Q1 237 128 M $4.51B
2021 Q4 231 128 M $5.36B
2021 Q3 231 128 M $6.27B
2021 Q2 198 114 M $4.77B
2021 Q1 144 98.4 M $3.51B
2020 Q4 119 97.4 M $2.73B